+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pain Management Therapeutics Market Research Report by Indication (Arthritic Pain, Cancer Pain, and Chronic Back Pain), Therapeutics, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4896709
  • Report
  • April 2022
  • Region: Global
  • 214 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca
  • Eli Lilly & Company
  • Endo Pharmaceuticals Inc.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
The Global Pain Management Therapeutics Market size was estimated at USD 75.66 billion in 2021, USD 79.04 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.64% to reach USD 99.33 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pain Management Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Indication, the market was studied across Arthritic Pain, Cancer Pain, Chronic Back Pain, Fibromyalgia, Migraine, Neuropathic Pain, and Post-Operative Pain.
  • Based on Therapeutics, the market was studied across Anesthetics, Anticonvulsants, Antidepressants, Antimigraine Agents, Non-narcotic Analgesics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), and Opioids.
  • Based on Distribution Channel, the market was studied across Hospitals Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pain Management Therapeutics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pain Management Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pain Management Therapeutics Market, including Abbott Laboratories, AstraZeneca, Eli Lilly & Company, Endo Pharmaceuticals Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson Services, Mallinckrodt Pharmaceuticals Company, Merck & Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pain Management Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pain Management Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pain Management Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Pain Management Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Pain Management Therapeutics Market?
6. What is the market share of the leading vendors in the Global Pain Management Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Pain Management Therapeutics Market?
Frequently Asked Questions about the Global Pain Management Therapeutics Market

What is the estimated value of the Global Pain Management Therapeutics Market?

The Global Pain Management Therapeutics Market was estimated to be valued at $75.7 Billion in 2021.

What is the growth rate of the Global Pain Management Therapeutics Market?

The growth rate of the Global Pain Management Therapeutics Market is 4.6%, with an estimated value of $99.3 Billion by 2027.

What is the forecasted size of the Global Pain Management Therapeutics Market?

The Global Pain Management Therapeutics Market is estimated to be worth $99.3 Billion by 2027.

Who are the key companies in the Global Pain Management Therapeutics Market?

Key companies in the Global Pain Management Therapeutics Market include Abbott Laboratories, AstraZeneca, Eli Lilly & Company, Endo Pharmaceuticals Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson Services, Mallinckrodt Pharmaceuticals Company and Novartis AG.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca
  • Eli Lilly & Company
  • Endo Pharmaceuticals Inc.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in incidences of chronic diseases
5.1.1.2. Growing geriatric population
5.1.1.3. Increase in incidence of accidental and sports injuries
5.1.2. Restraints
5.1.2.1. Availability of substitutes such as pain relief devices
5.1.2.2. The absence of a perfect pain management solution
5.1.3. Opportunities
5.1.3.1. Improving healthcare infrastructure in emerging countries
5.1.3.2. Ongoing research and development in the pain therapeutics
5.1.4. Challenges
5.1.4.1. Risk of side effects of pain medications such as sedation and nausea
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Pain Management Therapeutics Market, by Indication
6.1. Introduction
6.2. Arthritic Pain
6.3. Cancer Pain
6.4. Chronic Back Pain
6.5. Fibromyalgia
6.6. Migraine
6.7. Neuropathic Pain
6.8. Post-Operative Pain
7. Pain Management Therapeutics Market, by Therapeutics
7.1. Introduction
7.2. Anesthetics
7.3. Anticonvulsants
7.4. Antidepressants
7.5. Antimigraine Agents
7.6. Non-narcotic Analgesics
7.7. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
7.8. Opioids
8. Pain Management Therapeutics Market, by Distribution Channel
8.1. Introduction
8.2. Hospitals Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy
9. Americas Pain Management Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pain Management Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Pain Management Therapeutics Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. AstraZeneca
13.3. Eli Lilly & Company
13.4. Endo Pharmaceuticals Inc.
13.5. F. Hoffmann La Roche Ltd.
13.6. GlaxoSmithKline Plc
13.7. Johnson & Johnson Services
13.8. Mallinckrodt Pharmaceuticals Company
13.9. Merck & Co. Inc.
13.10. Novartis AG
13.11. Pfizer Inc.
13.12. Purdue Pharma L.P.
13.13. Teva Pharmaceutical Industries Ltd.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: DYNAMICS
FIGURE 2. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 3. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2027
FIGURE 5. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ARTHRITIC PAIN, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ARTHRITIC PAIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CANCER PAIN, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CANCER PAIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC BACK PAIN, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC BACK PAIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY FIBROMYALGIA, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY MIGRAINE, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY MIGRAINE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY POST-OPERATIVE PAIN, 2019-2027 (USD BILLION)
FIGURE 18. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY POST-OPERATIVE PAIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2021 VS 2027 (%)
FIGURE 20. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2021 VS 2027 (USD BILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2027
FIGURE 22. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANESTHETICS, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANESTHETICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIMIGRAINE AGENTS, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIMIGRAINE AGENTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-NARCOTIC ANALGESICS, 2019-2027 (USD BILLION)
FIGURE 31. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-NARCOTIC ANALGESICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2019-2027 (USD BILLION)
FIGURE 33. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2019-2027 (USD BILLION)
FIGURE 35. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 36. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 37. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD BILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 39. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS PHARMACY, 2019-2027 (USD BILLION)
FIGURE 40. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS PHARMACY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 41. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, 2019-2027 (USD BILLION)
FIGURE 42. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 43. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, 2019-2027 (USD BILLION)
FIGURE 44. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 45. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. AUSTRALIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. CHINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. INDIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. INDONESIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. JAPAN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. MALAYSIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. PHILIPPINES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. SINGAPORE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. SOUTH KOREA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. TAIWAN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. THAILAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. FRANCE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. GERMANY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. ITALY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. NETHERLANDS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. QATAR PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. RUSSIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. SAUDI ARABIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. SOUTH AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. SPAIN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. UNITED ARAB EMIRATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 74. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 75. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 76. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ARTHRITIC PAIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ARTHRITIC PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ARTHRITIC PAIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ARTHRITIC PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ARTHRITIC PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CANCER PAIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CANCER PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CANCER PAIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CANCER PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CANCER PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC BACK PAIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC BACK PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC BACK PAIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC BACK PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC BACK PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2019-2027 (USD BILLION)
TABLE 20. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY FIBROMYALGIA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY FIBROMYALGIA, BY STATE, 2019-2027 (USD BILLION)
TABLE 22. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY FIBROMYALGIA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY FIBROMYALGIA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY MIGRAINE, BY REGION, 2019-2027 (USD BILLION)
TABLE 25. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY MIGRAINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY MIGRAINE, BY STATE, 2019-2027 (USD BILLION)
TABLE 27. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY MIGRAINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY MIGRAINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 30. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 32. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY POST-OPERATIVE PAIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 35. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY POST-OPERATIVE PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY POST-OPERATIVE PAIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 37. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY POST-OPERATIVE PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY POST-OPERATIVE PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2019-2027 (USD BILLION)
TABLE 40. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANESTHETICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 41. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANESTHETICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANESTHETICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 43. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANESTHETICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANESTHETICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 46. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 48. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 51. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 53. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIMIGRAINE AGENTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 56. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIMIGRAINE AGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIMIGRAINE AGENTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 58. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIMIGRAINE AGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIMIGRAINE AGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-NARCOTIC ANALGESICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 61. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-NARCOTIC ANALGESICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-NARCOTIC ANALGESICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 63. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-NARCOTIC ANALGESICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-NARCOTIC ANALGESICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2019-2027 (USD BILLION)
TABLE 66. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY STATE, 2019-2027 (USD BILLION)
TABLE 68. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, BY REGION, 2019-2027 (USD BILLION)
TABLE 71. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 72. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, BY STATE, 2019-2027 (USD BILLION)
TABLE 73. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 75. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 76. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS PHARMACY, BY REGION, 2019-2027 (USD BILLION)
TABLE 77. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 78. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS PHARMACY, BY STATE, 2019-2027 (USD BILLION)
TABLE 79. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 81. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2019-2027 (USD BILLION)
TABLE 82. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 83. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2019-2027 (USD BILLION)
TABLE 84. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 86. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2019-2027 (USD BILLION)
TABLE 87. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 88. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2019-2027 (USD BILLION)
TABLE 89. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 91. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 93. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 96. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 97. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 98. AUSTRALIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 99. CHINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. INDIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 101. INDONESIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 102. JAPAN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 103. MALAYSIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 104. PHILIPPINES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 105. SINGAPORE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 106. SOUTH KOREA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 107. TAIWAN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 108. THAILAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 110. FRANCE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 111. GERMANY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 112. ITALY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 113. NETHERLANDS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 114. QATAR PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 115. RUSSIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 116. SAUDI ARABIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 117. SOUTH AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 118. SPAIN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 119. UNITED ARAB EMIRATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 120. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 121. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: SCORES
TABLE 122. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 123. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 124. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: RANKING
TABLE 125. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 126. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 127. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 128. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 129. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 130. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 131. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • AstraZeneca
  • Eli Lilly & Company
  • Endo Pharmaceuticals Inc.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services
  • Mallinckrodt Pharmaceuticals Company
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...